Secure CheckoutPersonal information is secured with SSL technology.
Free ShippingFree global shipping
No minimum order.
Insulin Resistance as a Risk Factor in Visceral and Neurological Disorders provides an overview on the risk factors for insulin resistance in visceral and neurological disorders. The book focuses on molecular mechanisms and signal transduction processes associated with the links. The comprehensive information in this monograph will not only help in the early detection of insulin resistance related visceral and neurological disorders, but also promote the discovery of new drugs which may block or delay onset in elderly patients. Understanding these processes is important not only for patients, caregivers and health professionals, but also for health policymakers who must plan for national resources.
- Presents the first comprehensive book dedicated to insulin resistance as a risk factor for neurological disorders
- Focuses on the molecular mechanisms and signal transduction processes associated with insulin resistance
- Discusses insulin resistance to heart disease, obesity, diabetes, stroke, Alzheimer’s, Parkinson’s, dementia and depression
Researchers in neuroscience, neurochemistry, neurology, and neuropharmacology; neurologists, physicians, and nutritionists
- Insulin resistance and obesity
2. Insulin resistance, diabetes, and metabolic syndrome
3. Insulin resistance and heart disease
4. Insulin resistance and sleep apnea
5. Insulin resistance and stroke
6. Insulin resistance and Alzheimer’s disease
7. Insulin resistance and Parkinson’s disease
8. Insulin resistance, dementia, and depression
9. Use of phytochemicals for the treatment of insulin resistance-linked visceral and neurological disorders
10. Summary and perspective for future research on insulin resistance and insulin resistance-linked visceral and neurological disorders
- No. of pages:
- © Academic Press 2020
- 1st March 2020
- Academic Press
- Paperback ISBN:
Akhlaq A. Farooqui is a leader in the field of signal transduction, brain phospholipases A2, bioactive ether lipid metabolism, polyunsaturated fatty acid metabolism, glycerophospholipid-, sphingolipid-, and cholesterol-derived lipid mediators, glutamate-induced neurotoxicity and modulation of signal transduction by phytochemicals. He has published more than 200 hundred papers, authored 11 monographs: Glycerophospholipids in Brain: Phospholipase A2 in Neurological Disorders (2007); Neurochemical Aspects of Excitotoxicity (2008); Metabolism and Functions of Bioactive Ether Lipids in Brain (2008); and Hot Topics in Neural Membrane Lipidology (2009); Beneficial Effects of Fish Oil in Human Brain (2009); Neurochemical Aspects of Neurotraumatic and Neurodegenerative Diseases (2010); Lipid Mediators and their Metabolism in the Brain (2011); Phytochemicals, Signal Transduction, and Neurological Disorders (2012); Metabolic Syndrome: An Important Risk Factor for Stroke, Alzheimer Disease, Depression (2013); Inflammation and Oxidative Stress in Neurological Disorders (2014); High Calorie Diet and the Human Brain: Consequences of Long Term Consumption (2015); Therapeutic Potentials of Curcumin for Alzheimer Disease (2016). All monographs are published by Springer, New York. Akhlaq A. Farooqui has edited 10 books published by Wiley Blackwell Publishing Company, New York; Nova Science Publisher, New York; Bentham Science Publishers, Dubai, and Elsevier, San Diego, CA.
Research Scientist, Department of Molecular and Cellular Biochemistry, The Ohio State University, Columbus, OH, USA